Skip to main content

Table 2 Clinical data of the 199 end-stage liver disease (Child-Pugh class A, child B, and child C)

From: Evaluation of seven gene signature for predicting HCV recurrence post-liver transplantation

 

End-stage liver disease patients

Child A

Child B

Child C

P value

N=79

N=43

N=77

 

Age

60 a

(55–64)

55b

(51–60)

52c

(48.50–57)

<0.001 HS

Hb.%

12.5 a

(11–13.70)

12 b

(10.70–13)

12b

(11–13)

0.031

WBCsX103

5.30 a

(4.30–6.50)

5.10 a

(4–6)

5.60 a

(4–6.95)

0.6

PlateletsX103

130 b

(96–160)

156 ab

(90–180)

165 a

(121–210)

<0.001 HS

ALT

43 a

(34–50)

40 a

(33–47)

46 a

(30–110)

0.09

AST

52 a

(45–63)

48 a

(29–65)

46 a

(21.5–86.5)

0.509

Alb.

3.50 b

(3.20–3.80)

3.40 b

(2.80–3.80)

3.80 a

(3.45–4.00)

<0.001 HS

Creat.

1.00 a

(0.90–1.10)

1.00 a

(0.90–1.10)

1.00 a

(0.90–1.10)

0.86

  1. Data are expressed as median (IQR). Hb. states to hemoglobin, ALT states to serum alanine aminotransferase, and AST states to serum aspartate aminotransferase, Alb. states to albumin
  2. Identical letters in rows mean no significant difference at the level of 0.05
  3. Different letters in rows mean significant difference at the level of 0.05
  4. HS means highly significant